4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-075221
Senior VP, Chief Pharma Dev. sold 1,900 shares at $280.00 ($532,000)
- Senior VP, Chief Pharma Dev. acquired 1,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-06-14 | Option exercise | +1,900 | $87.09 | $165,471 | 7,400 | D |
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-06-14 | Sale | −1,900 | $280.00 | $532,000 | 5,500 | D |
| Derivatives | |||||||
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-06-14 | Option exercise · Stock Option (Right to Buy) | −1,900 | 10,350 | D | ||
| Open-market sales · 1,900 sh · avg $280.00 · $532,000 | |||||||
Loading xslF345X05/ownership.xml…